Mimetas
Mimetas is a Dutch company based in Leiden, which specializes in developing organ-on-a-chip models for drug development. Founded in 2013, they raised $32.4M from multiple investors.
The company provides OrganoServices for compound profiling or screening in the human-relative models. Combined with their OrganoPlates, the screening can be performed for multiple compounds using just one plate.
